Recent Advances in Cardiovascular Therapies

Program Release: April 16, 2021
Expiration Date: April 16, 2022
Estimated time to complete: 120 Minutes
There are no prerequisites for participation.

Program Description
Recent advances in diagnostic modalities and therapeutic options for patients with known or suspected cardiac disease have emerged at a fast pace. Novel treatments for disease management may not be integrated into day-to-day clinical practice due to insufficient knowledge of these new treatment strategies, as well as uncertainty in the selection of appropriate diagnostic and therapeutic options for the right patient, at the right time.

Method of Participation and How to Receive CME Credit

• Review the activity objectives, faculty information, and CME information prior to participating in the activity.
• View the two CME presentations
• Complete the CME activity post-test and evaluation at the conclusion of the activity in order to receive a credit certificate.

Faculty Disclosure

In accordance with the disclosure policy of the Brown University CME Office as well as standards set forth by the Accreditation Council on Continuing Medical Education (ACCME), speakers have been asked to disclose any relevant financial relationship with the manufacturers of any commercial products and/or provider of commercial services discussed in any educational presentation and with any commercial supporters or exhibitors of this activity.

The intent of this policy is not to prevent a speaker with a potential conflict of interest from making a presentation but to identified openly so that the listener may form his/her own opinion. Any potential conflicts of interest have been resolved prior to this presentation.

This activity may include discussion of off-label or investigative drugs uses. Speakers are aware that it is their responsibility to disclose to the audience this information. Individual Faculty Disclosure information may be found in the conference handouts.

Faculty Disclosure/Conflict of Interest
The following speaker and planning committee members* have disclosed that they have no relevant financial relationships:

Brian G. Abbott, MD, FACC, MASNC, FAHA*
Herbert D. Aronow, MD, MPH^
Michael K. Atalay, MD, PhD, FSCCT, FSCMR
Leanne Burke, MSN, APRN-CNP, ANP-BC
Afshin Ehsan, MD*
Omar N. Hyder, MD
Daniel J. Levine, MD
Daniel M. Philbin, Jr., MD FACC FHRS
Athena Poppas, MD, FACC, FASE*
Barry L. Sharaf, MD
Frank W. Sellke, MD
Neel R. Sodha, MD
Maria Sullivan, BS*

^Speaker has indicated their presentation will include discussion of unlabeled/investigational use of a commercial product.

Disclaimer and Privacy Policy

Privacy Policy: The Office of Continuing Medical Education (CME) and its educational partners protect the privacy of personal and other information regarding participants and educational collaborators. The CME Office maintains its Internet site as an information resource and service for physicians, other health professionals, and the public. The CME Office will keep your personal information confidential when you participate in a CME Internet-based program. CME collects only the information necessary to provide you with the services that you request.

Disclaimer: This educational program is designed to present scientific information and opinion to Health professionals, to stimulate thought, and further investigation.